Enzymatica changes Certified Adviser to Carnegie Investment Bank AB (publ)

Enzymatica AB (publ) has entered into an agreement with Carnegie Investment Bank AB (publ) regarding the position as Certified Adviser. Carnegie Investment Bank AB will take over as Certified Adviser today, November 30, 2023. The change follows Carnegie Investment Bank’s acquisition of Erik Penser Bank, which was previously Enzymatica’s Certified Adviser.

FOR MORE INFORMATION, PLEASE CONTACT:
 

Stefan Olsson, Communication Manager, Enzymatica AB
Phone: +46 (0) 708 55 11 85 | Email: stefan.olsson@enzymatica.com

Enzymatica AB is headquartered in Lund, Sweden, and is listed on Nasdaq First North Growth Market. For more information, please visit www.enzymatica.com. Enzymatica’s Certified Adviser is Carnegie Investment Bank AB (publ).